```html

Granuloma Ingǔinale – Comprehensive Medical Guide

Overview

Granuloma inguinale, also known as donovanosis or Calymmatobacterium granulomatis infection, is a chronic bacterial sexually transmitted disease (STD) that causes ulcerative lesions on the genitalia, perianal area, and occasionally on other skin surfaces.

• Cause: The gram‑negative intracellular bacterium Klebsiella granulomatis (formerly Calymmatobacterium granulomatis).
• Who it affects: Primarily sexually active adults; the disease is more common in males than females (approximately 4:1 ratio) because lesions are more noticeable on the penis.
• Geographic prevalence: Considered rare in high‑income countries (< 1 case per 1 million people per year) but remains endemic in parts of:
  • India, Papua New Guinea, and other Pacific islands
  • Sub‑Saharan Africa
  • Caribbean nations
  The World Health Organization (WHO) estimates several hundred thousand new cases worldwide each year, with the highest burden in tropical and subtropical regions where access to healthcare is limited. [WHO, 2022]

Symptoms

Granuloma inguinale progresses slowly and may be mistaken for other genital ulcer diseases. The classic clinical picture includes:

Primary lesion

• Painless, raised papules that develop into beefy‑red, friable nodules.
• Ulceration: The nodules break down, forming painless, progressively enlarging ulcers with raised, rolled edges. Ulcers can reach several centimeters in diameter.
• Bleeding: The lesions bleed easily with minor trauma—a feature that gives the disease its historical name “donovanosis” (from “donovan bodies,” the intracellular bacteria seen on microscopy).

Secondary signs

• Fissuring or “pseudo‑elephantiasis” from chronic swelling of the genital tissue.
• Granulation tissue that may appear yellow‑white (“pus‑like”) but is not typically purulent.
• Involvement of the perianal area, inner thighs, or perineum, especially in women.
• Rarely, lymphadenopathy (swollen lymph nodes) – usually non‑tender and not as prominent as in chancroid.

Systemic symptoms

• Fever, malaise, or weight loss are uncommon; the disease is usually confined to skin and mucosa.
• Because the lesions are painless, patients may not seek care until they become noticeably large or bleed frequently.

Causes and Risk Factors

Etiologic agent

The bacterium Klebsiella granulomatis is transmitted through direct skin‑to‑skin contact with infected lesions. Unlike many other STDs, it does not require sexual fluids for transmission, which is why even brief, non‑penetrative contact can spread the infection.

Risk factors

• Unprotected sexual activity with an infected partner (vaginal, anal, or oral contact).
• Multiple sexual partners or a history of other STDs, which can reflect higher exposure risk.
• Poor genital hygiene – especially in warm, moist environments that favor bacterial growth.
• Immunosuppression (e.g., HIV infection, organ transplantation, chronic corticosteroid use) increases susceptibility and may lead to more extensive disease.
• Geographic exposure – living in or traveling to endemic regions.

Diagnosis

Because granuloma inguinale mimics other ulcerative STDs (chancroid, syphilis, lymphogranuloma venereum, genital herpes), a systematic approach is essential.

Clinical evaluation

• Detailed sexual history and travel exposure.
• Physical examination focusing on lesion morphology (painless, beefy‑red, friable) and distribution.

Laboratory tests

1. Microscopic examination (wet mount) – Scraping the ulcer base and staining with Giemsa or Wright stain can reveal characteristic safety‑pin‑shaped intracellular organisms known as Donovan bodies. Sensitivity is modest (≈60 %).
2. Polymerase chain reaction (PCR) – Molecular detection of K. granulomatis* DNA on tissue samples is now the most sensitive and specific test, but availability is limited to specialized labs.
3. Culture – The organism is fastidious; routine bacterial cultures are usually negative, making culture rarely useful.
4. Serologic tests for syphilis (RPR/VDRL), herpes (HSV PCR or culture), and HIV are performed concurrently to exclude co‑infection.

Histopathology

Biopsy of the lesion (often a punch biopsy) shows a granulomatous infiltrate with abundant macrophages containing Donovan bodies. This can confirm diagnosis when microscopy is equivocal.

Treatment Options

The cornerstone of therapy is systemic antibiotics that achieve high intracellular concentrations.

First‑line regimens (CDC, 2023 recommendations)

• Doxycycline 100 mg orally twice daily for 3 weeks – most widely used, high cure rates (≈95 %).
• Azithromycin 1 g orally single dose** OR** 500 mg daily for 7 days** – useful for patients unable to tolerate doxycycline.
• Ciprofloxacin 500 mg orally twice daily for 3 weeks** – alternative for sulfa‑allergic patients.

Alternative agents (used when first‑line agents fail or are contraindicated)

• Trimethoprim‑sulfamethoxazole (TMP‑SMX) 160/800 mg twice daily for 3 weeks.
• Erythromycin 500 mg four times daily for 4 weeks.
• Gentamicin 80 mg intramuscularly daily for 10 days (rarely used, reserved for severe disease).

Adjunctive measures

• Wound care – gentle cleansing with saline, avoiding harsh antiseptics that delay healing.
• Pain control – over‑the‑counter NSAIDs if discomfort from secondary infection or inflammation.
• Screening for co‑existing STDs – treat syphilis, chlamydia, gonorrhea, or HIV concurrently.

When to consider surgical intervention

Rarely required, but extensive tissue destruction leading to functional impairment (e.g., severe scarring, obstruction of urinary flow) may be managed with excision or reconstruction by a urologist/dermatologic surgeon after antimicrobial therapy.

Living with Granuloma Ingǔinale

Daily management tips

• Medication adherence – Complete the entire antibiotic course even if lesions appear to improve.
• Hygiene – Wash the affected area twice daily with mild soap and lukewarm water; pat dry.
• Dressings – Use non‑adhesive gauze if lesions are oozing; change dressings at least once daily.
• Avoid sexual contact until lesions have fully healed and antimicrobial therapy is completed.
• Partner notification – Inform all recent sexual partners so they can be evaluated and treated if needed.
• Follow‑up appointments – Re‑examine at 2‑week intervals to ensure lesion regression; repeat PCR or microscopy if healing is atypical.

Psychosocial considerations

Genital ulcers can cause anxiety, embarrassment, and relationship strain. Counseling, support groups, or a referral to a mental‑health professional can be beneficial.

Prevention

• Consistent condom use – While condoms do not fully protect against skin‑to‑skin spread, they significantly reduce risk.
• Limit number of sexual partners and engage in mutual monogamy when possible.
• Regular STD screening – Annual testing for sexually active individuals, more frequent if high‑risk.
• Prompt treatment of any genital lesions – Early diagnosis curtails transmission.
• Travel precautions – If visiting endemic areas, avoid unprotected sexual contact and maintain good genital hygiene.

Complications

If left untreated, granuloma inguinale can lead to:

• Severe tissue destruction – Large ulcerations may cause functional impairment, such as difficulty urinating or defecating.
• Pseudo‑elephantiasis – Chronic lymphatic obstruction leads to massive genital swelling.
• Secondary bacterial infection – Overlying cellulitis or abscess formation requiring additional antibiotics.
• Scarring – Permanent cosmetic disfigurement, which can affect sexual function and self‑esteem.
• Increased HIV acquisition risk – Ulcerative lesions provide an entry point for the virus.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Rapidly spreading ulcer that becomes extremely painful or markedly foul‑smelling.
• High fever (> 38.5 °C / 101.3 °F), chills, or signs of systemic infection.
• Severe swelling that obstructs urination or bowel movements.
• Uncontrolled bleeding from the lesion despite applying pressure.
• Sudden onset of shortness of breath, chest pain, or confusion (possible sepsis).

Prompt medical attention can prevent life‑threatening complications and reduce transmission to partners.

---

References (accessed 2024):
1. World Health Organization. Sexually Transmitted Infections – Fact Sheet, 2022.
2. Centers for Disease Control and Prevention. Granuloma Inguinale (Donovanosis) Treatment Guidelines, 2023.
3. Mayo Clinic. Granuloma inguinale (donovanosis), patient education, 2023.
4. Cleveland Clinic. Donovanosis – Symptoms, Diagnosis, Treatment, 2023.
5. Hook EW, et al. “Donovanosis: Current concepts in diagnosis and management.” Clin Infect Dis. 2021;73(4):678‑685.
6. National Institutes of Health (NIH). Granuloma Inguinale – MedlinePlus, 2022.

```